High SVR Rates Achieved with Simplified Monitoring in Japanese Patients with HCV Infection Treated with Sofosbuvir/Velpatasvir: A Prospective multicenter Study

Conference Reports for NATAP

The Liver Meeting
AASLD 2025
Washington, D.C.
November 7-11, 2025


High SVR Rates Achieved with Simplified Monitoring in Japanese Patients with HCV Infection Treated with Sofosbuvir/Velpatasvir: A Prospective multicenter Study

	AASLD 2025 Nov 7-11 Wash DC < Goki Suda